Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues.
- 1 July 1987
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 84 (13), 4408-4412
- https://doi.org/10.1073/pnas.84.13.4408
Abstract
An aberrant p210BCR-ABL protein that possesses constitutive protein-tyrosine kinase activity is presumed to be involved in the development of the neoplastic phenotype in chronic myelogenous leukemia (CML). Using a highly specific antibody against phosphotyrosine, we have isolated the tyrosine-phosphorylated p210BCR-ABL and several other proteins containing phosphotyrosine from a variety of CML cell lines. p210BCR-ABL isolated by the monoclonal anti-phosphotyrosine antibody possessed protein-tyrosine kinase activity in vitro comparable to that of the p210BCR-ABL isolated by antibody to a specific peptide sequence in the ABL protein-tyrosine kinase. Other prominent proteins containing phosphorylated tyrosine residues were observed at 185, 150, 120, 105, 63, 56, 36, and 32 kDa, and less prominent proteins were observed at 195, 155, 94, 53, 40, and < 29 kDa. Staphylococcal V8 peptide mapping indicated that proteins of similar molecular weights were highly homologous to each other across cell lines, despite the diverse hematopoetic lineages of these cells and the genetic heterogeneity of the patients from whom the CML cell lines were derived. Phosphopeptide mapping also revealed that these proteins were distinct from each other as well as from p210BCR-ABL. Because virtually identical phosphotyrosine-containing proteins were found in peripheral blood leukocytes taken directly from CML patients, these proteins are not an artifact of long-term tissue culture but appear to be an integral part of the CML phenotype.Keywords
This publication has 67 references indexed in Scilit:
- Protein phosphorylation at tyrosine residues INv-abl transformed mouse lymphocytes and fibroblastsInternational Journal of Cancer, 1986
- Evidence of a New Chimericbcr/c-ablmRNA in Patients with Chronic Myelocytic Leukemia and the Philadelphia ChromosomeNew England Journal of Medicine, 1985
- Association of specific tyrosine phosphorylation with stages of B-cell differentiation in human lymphoid leukemiasBiochemical and Biophysical Research Communications, 1985
- The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1Cell, 1985
- Enhanced tyrosine phosphorylation in B lymphocytes upon complexing of membrane immunoglobulinBiochemical and Biophysical Research Communications, 1984
- Altered Transcription of the c- abl Oncogene in K-562 and Other Chronic Myelogenous Leukemia CellsScience, 1984
- HEL Cells: A New Human Erythroleukemia Cell Line with Spontaneous and Induced Globin ExpressionScience, 1982
- Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosineNature, 1980
- K562 human leukaemic cells synthesise embryonic haemoglobin in response to haeminNature, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970